・The Institute for Virus Research, Kyoto University
・The Translatioal Research Center, Kyoto University Hospital
・The National Institute of Advanced Industrial Science and Technology
The Institute for Virus Research, Kyoto University , the Translatioal Research Center, Kyoto University Hospital and the National Institute of Advanced Industrial Science and Technology have formed a closely knit network focusing on the key concept of oxidation-reduction. RBS was established as a result of this powerful and efficient collaboration between the industrial and academic sectors, and operates as a bridge to bring the results of basic oxidation-reduction research to society. RBS has launched its innovative and unique business operations in the areas of pharmaceuticals, foods and stress measurement.
The Translatioal Research Center (TRC), Kyoto University Hospitalconcentrates on the clinical applications of thioredoxin and drug creation. TRC was established in 2001 with the aim of promoting world-leading innovative and advanced medicine and healthcare in Japan. The Center promotes the development of advanced medicine based on cooperation and collaboration between industry, academia, and government as one of the national centers established throughout the country. It consists of three departments: the Department of Experimental Therapeutics, the Department of Clinical Trial Design and Management, and the Department of Clinical Trials (Clinical Innovative Medicine?).
The Institute for Virus Research (IVR), Kyoto University was established for the purpose of contributing to the substantial improvement of medicine and biology through basic virus research. In particular, the Department of Biological Responses, Laboratory of Infection & Prevention, IVR is engaged in basic research on oxidation-reduction signals focusing on thioredoxin, a protein that is responsible for controlling oxidative stress in the body, the importance of which is becoming increasingly evident.
The National Institute of Advanced Industrial Science and Technology (AIST) has designated RBS as an approved venture as its business partner. AIST is engaged in developing methods for measuring and relieving stress, and permits the preferential use of its intellectual property rights and the use of its equipment for the commercialization of stress measurement and diagnosis by using stress-responsive molecules. The Institute is also pressing ahead with research exchanges with universities as well as mutual cooperation with private firms including venture corporations, with the aim of promoting a more efficient return to society of the fruits of intellectual production.
